Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-03COCP3Power of Attorney for Cocrystal Pharma, Inc. Officer
This filing is an Exhibit 24, a Power of Attorney document for James Sapirstein, Chief Executive Officer of Cocrystal Pharma, Inc. (COCP). Sapirstein appoints James Martin and Michael D. Harris as his attorneys-in-fact. This grants them the authority to prepare and execute Forms 3, 4, and 5 for Sapirstein in accordance...
Nano CapBiotechnology
2026-06-02ACHV3Form 3 Filing for Jeffrey S. Farrow - Officer/Director ChangeMEDIUM
This filing is an initial report (Form 3) for Jeffrey S. Farrow, an insider of ACHIEVE LIFE SCIENCES, INC. The report indicates that Mr. Farrow, who holds a director position, currently beneficially owns no securities in the company. The filing was signed on May 29, 2026. Additionally, an exhibit (EX-24) provides a Lim...
Small CapBiotechnology
2026-06-02ACHV3Form 3 Filing for Reid Waldman
This filing reports that Reid Waldman, a director at ACHIEVE LIFE SCIENCES, INC. (ACHV), has no securities beneficially owned following a transaction as of May 29, 2026. The filing includes a Limited Power of Attorney, appointing Sandra Thomson to execute and file necessary SEC forms (3, 4, 5) on behalf of Mr. Waldman....
Small CapBiotechnology